Aspire Capital Fund LLC 13D and 13G filings for Cyclacel Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2020-12-23 4:42 pm Purchase |
2020-12-23 | 13G | Cyclacel Pharmaceuticals, Inc. CYCC |
Aspire Capital Fund LLC | 18,000 5.050% |
18,000 (New Position) |
Filing |